• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 789-803 of 978 results

1098 Exhibit: Exhibit 1098 Ramsey Business Insider allergan history

Document IPR2016-01131, No. 1098-145 Exhibit - Exhibit 1098 Ramsey Business Insider allergan history (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

2044 Exhibit: FDA label for Xiidra

Document IPR2016-01131, No. 2044-58 Exhibit - FDA label for Xiidra (P.T.A.B. Mar. 20, 2017)

cite Cite Document
Analyze

2014 Exhibit: Lallemand et al Cyclosporine a Delivery to the Eye

Document IPR2016-01131, No. 2014-32 Exhibit - Lallemand et al Cyclosporine a Delivery to the Eye (P.T.A.B. Mar. 20, 2017)

cite Cite Document
Analyze

1152 Exhibit: EX1152 AAM White Paper Renting Tribal Immunity to Evade IPR Revi...

Document IPR2016-01131, No. 1152-235 Exhibit - EX1152 AAM White Paper Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents (P.T.A.B. Oct. 13, 2017)

cite Cite Document
Analyze

1135 Exhibit: Exhibit 1135 July 6, 2017 Email

Document IPR2016-01131, No. 1135-195 Exhibit - Exhibit 1135 July 6, 2017 Email (P.T.A.B. Aug. 3, 2017)

cite Cite Document
Analyze

1107 Exhibit: Exhibit 1107 Allergan Q1 2009 Earnings Call

Document IPR2016-01131, No. 1107-154 Exhibit - Exhibit 1107 Allergan Q1 2009 Earnings Call (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

1101 Exhibit: Exhibit 1101 Allergan Q2 2016 Earnings Call

Document IPR2016-01131, No. 1101-148 Exhibit - Exhibit 1101 Allergan Q2 2016 Earnings Call (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

2032 Exhibit: Drugs at FDA FDA Approved Drug Products

Document IPR2016-01131, No. 2032-49 Exhibit - Drugs at FDA FDA Approved Drug Products (P.T.A.B. Mar. 20, 2017)

cite Cite Document
Analyze

2008 Exhibit: RESTASIS label

Document IPR2016-01131, No. 2008-13 Exhibit - RESTASIS label (P.T.A.B. Sep. 9, 2016)

cite Cite Document
Analyze

1154 Exhibit: EX1154 Excerpted Allergans Response to Motion for Summary Juge...

Document IPR2016-01131, No. 1154-237 Exhibit - EX1154 Excerpted Allergans Response to Motion for Summary Jugement (P.T.A.B. Oct. 13, 2017)

cite Cite Document
Analyze

1136 Exhibit: Exhibit 1136 July 21, 2017 Email

Document IPR2016-01131, No. 1136-196 Exhibit - Exhibit 1136 July 21, 2017 Email (P.T.A.B. Aug. 3, 2017)

cite Cite Document
Analyze

1058 Exhibit: Exhibit 1058 Oellerich et al

Document IPR2016-01131, No. 1058-105 Exhibit - Exhibit 1058 Oellerich et al (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

1027 Exhibit: Exhibit 1027 Allergan Report No PK 00 163 2000 PK Study

Document IPR2016-01131, No. 1027-75 Exhibit - Exhibit 1027 Allergan Report No PK 00 163 2000 PK Study (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

1076 Exhibit: Exhibit 1076 Xiidra

Document IPR2016-01131, No. 1076-123 Exhibit - Exhibit 1076 Xiidra (P.T.A.B. Jun. 30, 2017)

cite Cite Document
Analyze

2023 Exhibit: Deposition transcript of Mansoor Amiji, PhD

Document IPR2016-01131, No. 2023-41 Exhibit - Deposition transcript of Mansoor Amiji, PhD (P.T.A.B. Mar. 20, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 53 54 55 56 57 ... >>